What is the clinical evidence from this study?

Study design: Review. Population: Atrial fibrillation. Intervention: Device-detected atrial fibrillation.

What does this research mean for the field?

Subclinical atrial tachyarrhythmias detected by cardiac implantable electronic devices carry an increased risk of thromboembolic events that warrants timely anticoagulation based on standard stroke risk stratification. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the epidemiology, mechanisms of stroke, and clinical implications of subclinical atrial fibrillation detected by cardiac implantable electronic devices.

August 21, 2026Journal of the American College of CardiologyOpen Access

Device-Detected Atrial Fibrillation

View Full Paper

Ask AI

Bookmark

Key result

Review summarizes AF epidemiology, stroke mechanisms, and clinical implications of device-detected atrial tachyarrhythmias.

Why the study?

Despite evidence linking device-detected subclinical atrial tachyarrhythmias to increased thromboembolic risk, clinical intervention remains sluggish, with clinicians often delaying treatment for continued surveillance.

Key Points

To review the epidemiology, mechanisms of stroke, and clinical implications of subclinical atrial fibrillation detected by cardiac implantable electronic devices.
Narrative review evaluating the relationship between device-detected subclinical atrial tachyarrhythmias and thromboembolic risk.
Synthesizes evidence regarding clinical practice guidelines and stroke risk stratification tools, specifically the CHA2DS2-VASc score.
Subclinical atrial tachyarrhythmias detected by implanted electronic devices are linked to an increased risk of thromboembolism, regardless of symptoms.
Updated clinical practice guidelines recommend oral anticoagulation for nonvalvular atrial fibrillation in patients with a CHA2DS2-VASc score ≥2, irrespective of whether episodes are paroxysmal, persistent, or permanent.

Structured PICO

Population

Patients with atrial fibrillation, specifically focusing on subclinical atrial tachyarrhythmias detected by cardiac implantable electronic devices.

This review discusses the epidemiology, stroke mechanisms, and clinical implications of device-detected atrial fibrillation, emphasizing guideline-directed anticoagulation based on stroke risk scores.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Device-detected ATs may elevate thromboembolic risk; leaves open optimal anticoagulation threshold pending randomized data.

Cite This Study

Chen‐Scarabelli et al. (2015) conducted a review in Atrial fibrillation. Device-detected atrial fibrillation was evaluated. This review discusses the epidemiology of atrial fibrillation, mechanisms of stroke, and the clinical implications of device-detected atrial tachyarrhythmias.

synapsesocial.com/papers/6a88c0c2f0c2079f0c0124dc https://doi.org/10.1016/j.jacc.2014.10.045

Topics

Atrial fibrillation Anticoagulation in AF Persistent AF management

View Full Paper

Ask AI

Bookmark

Device-Detected Atrial Fibrillation

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Device-Detected Atrial Fibrillation

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider